Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More
-
Veterinary Molecular Diagnostics
... at a CAGR of 7.5% over the analysis period 2024-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$342.8 Million by the end ... Read More
-
Lung Cancer Diagnostics
... at a CAGR of 7.8% over the analysis period 2024-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.3 Billion by the end of ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More
-
ATP Assay
... CAGR of 7.1% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$487.0 Million by the end of the ... Read More
-
Automated Liquid Handling (ALH) Technologies
... Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More
-
Blood Group Typing
... at a CAGR of 9.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$2.8 Billion by the end of the ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
-
3D CBCT / Cone Beam CT Systems
... expected to reach US$1.2 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Dental, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and ... Read More
-
Aptamers
... 15.7% over the analysis period 2024-2030. DNA Aptamers, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$227.5 Million by the end of the analysis period. Growth ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Automated Blood Tube Labelers and Specimen Transport Boxes
... 2024, is expected to reach US$518.8 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 7.4% ... Read More
-
Biochemistry Analyzers
... CAGR of 5.4% over the analysis period 2024-2030. Clinical Diagnostics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.4 Billion by the end of the analysis ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More
-
Breast Cancer Screening
... at a CAGR of 5.1% over the analysis period 2024-2030. Imaging Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.8 Billion by the end of ... Read More
-
Cardiac Ablation
... CAGR of 10.7% over the analysis period 2024-2030. Cardiac Rhythm Management, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$1.8 Billion by the end of the ... Read More
-
Cardiopulmonary Autotransfusion Systems
... at a CAGR of 2.2% over the analysis period 2024-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end ... Read More
-
Cardiovascular Ultrasound Systems
... at a CAGR of 5.1% over the analysis period 2024-2030. 2D, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
CBCT / Cone Beam Imaging
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Dental, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.2 Billion by ... Read More
-
Cell Isolation / Cell Separation
... Billion by 2030, growing at a CAGR of 16.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 19.5% CAGR and reach US$35.0 Billion by ... Read More
-
Cell Viability Assays
... at a CAGR of 7.1% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by the end of the ... Read More
-
Cell Signaling
... CAGR of 5.4% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$4.5 Billion by the end of the analysis period. ... Read More
-
Cell Sorting
... CAGR of 9.2% over the analysis period 2024-2030. Cell Sorters, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$862.0 Million by the end of the analysis ... Read More
Research Assistance
